CVS Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$58.01 |
| 52 Week High | US$83.25 |
| 52 Week Low | US$52.71 |
| Beta | 0.54 |
| 11 Month Change | 2.69% |
| 3 Month Change | -1.18% |
| 1 Year Change | -16.44% |
| 33 Year Change | -36.61% |
| 5 Year Change | -22.93% |
| Change since IPO | 8,735.96% |
Recent News & Updates
Recent updates
There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings
Nov 19
CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21Shareholder Returns
| CVS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 9.1% | 1.6% | 2.2% |
| 1Y | -16.4% | 2.1% | 31.6% |
Return vs Industry: CVS underperformed the US Healthcare industry which returned 2.1% over the past year.
Return vs Market: CVS underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CVS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | US$73.00b |
| Earnings (TTM) | US$5.02b |
| Revenue (TTM) | US$367.25b |
14.6x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVS perform over the long term?
See historical performance and comparison